Position in HROW
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,574,473
+$12,876,559 QoQ
Shares Held
319,625
+1959.0% QoQ
Ownership
0.853%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#16
of 221 holders
Holding Since
Sep 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HROW Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $64,099,635 across 21 Drug Manufacturers - Specialty & Generic names. HROW ranks #1 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HROW |
Harrow, Inc.
This page
|
319,625 | $13,574,473 | |
| 2 | ALKS |
Alkermes plc.
|
195,174 | $10,227,117 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
710,816 | $7,108,160 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
130,982 | $5,374,191 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
305,991 | $5,296,704 | |
| 6 | ZTS |
Zoetis Inc.
|
63,752 | $4,581,218 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
41,217 | $3,411,943 | |
| 8 | HLN |
Haleon plc
|
363,872 | $3,394,925 |
All Filings in HROW
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,574,473 | 319,625 | Shares | Sole | 2026-08-14 | |
| 2024-09-30 | $697,914 | 15,523 | Shares | Sole | 2024-11-14 | |
| 2023-03-31 | $321,229 | 15,181 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $138,805 | 11,500 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||